Novee Launches PWNBench, a Benchmark for Agentic Penetration Testing, on Fireworks Specialized Intelligence Index

Novee launched PWNBench-v0.1 on Fireworks' Specialized Intelligence Index, a live-web-application benchmark for evaluating agentic AI penetration testing across recall, precision and API cost. Initial results showed Grok 4.5, Grok 4.6 and DeepSeek-V4-Flash-0731 on the cost-efficiency frontier, while Claude Opus 5 delivered the highest recall at 51% for roughly $1,400 in API spend at k=3, versus Kimi K3's 42% recall for $209. The release provides security teams with a practitioner-built framework to assess model tradeoffs in offensive-security workflows.

Analysis

This is primarily validation of a new evaluation category rather than a near-term earnings event for public equities. The commercial implication is that security buyers may increasingly optimize model selection by workload-specific precision, recall, and inference cost, favoring a multi-model architecture over a single foundation-model vendor. That raises switching costs for proprietary security platforms that own workflow integration, exploit validation, remediation, and audit trails; it is less clearly positive for any standalone model provider because benchmark leadership can rotate quickly with each model release.

The relevant 6-18 month second-order effect is margin pressure on AI-native cybersecurity vendors that rely on premium closed-model inference: a high-recall workflow can become uneconomic if customers demand continuous testing at scale. Conversely, lower-cost open or specialized models could expand the addressable market for continuous offensive-security testing, benefiting platforms able to convert cheaper inference into subscription gross-margin expansion. The press release does not establish customer adoption, benchmark independence, recurring revenue, or pricing power, so it should not be treated as evidence of monetization.

CAN appears to have no disclosed operating linkage to the announcement; its inclusion likely reflects Canaan Partners' private investment activity rather than Canaan Inc.'s crypto-mining business. DOCS has modest narrative relevance through its participation in domain-specific AI benchmarking, but no identifiable revenue sensitivity absent evidence that the benchmark informs Doximity product usage, provider retention, or AI-related monetization. Consensus may overread public benchmark visibility as a durable moat: benchmark results are marketing assets until procurement teams standardize on them and demonstrate willingness to pay for higher-performing agentic workflows.

Key Decisions for Investors

• No directional position in CAN or DOCS on this release. Treat CAN as an unrelated-ticker false signal; a position would require an independent Bitcoin-mining, ASIC-demand, or balance-sheet catalyst.
• Place a 1-3 month watch on DOCS for evidence that domain-specific evaluation is being embedded into paid clinical workflow products: monitor AI-product guidance, net revenue retention, and commentary on enterprise adoption. Upgrade only if management quantifies incremental revenue or retention; otherwise benchmark participation is immaterial.
• For cybersecurity exposure, monitor public platform vendors with AI-security workflow exposure such as PANW, CRWD and TENB for indications that continuous AI-driven testing is displacing point-in-time penetration testing. A long platform/short services-heavy security pair is only actionable after procurement data shows budget reallocation; falsify on stable services spend and no AI-security attach-rate improvement over two reporting periods.
• Watch model-inference pricing and security-agent accuracy over the next two model cycles. A sustained decline in cost per validated finding, rather than headline benchmark rank, would be the catalyst for broader security-software gross-margin upside; absent that data, avoid paying a multiple premium for the theme.